Development of a prediction model for hemorrhagic transformation after intravenous thrombolysis in patients with acute ischemic stroke: a retrospective analysis

建立急性缺血性卒中患者静脉溶栓后出血性转化预测模型:一项回顾性分析

阅读:2

Abstract

BACKGROUND: Hemorrhagic transformation (HT) is a serious and common complication following intravenous thrombolysis in acute ischemic stroke (AIS), often leading to worsened outcomes. Identifying risk factors for HT and developing accurate predictive models are essential for improving patient management and prognosis. METHODS: A retrospective analysis was performed on 159 patients with acute ischemic stroke who received intravenous thrombolytic therapy at Hubei Third People's Hospital Affiliated to Jianghan University School of Medicine from March 2019 to July 2022. Boruta algorithm and multivariable logistic regression analysis were used to identify independent factors associated with bleeding transformation. A nomogram was built based on these factors and internally verified using the bootstrap resampling method. RESULTS: Our analysis showed that the independent factors affecting HT were Hyperdense middle cerebral artery sign (HMCAS), pre-thrombolytic glucose, pre-thrombolytic neutrophil count and construct a nomogram based on these predictors. The area under the ROC curve (AUC) of the line graph was 0.885 (95%CI = 0.816 ~ 0.953), and the calibration curve showed that the probability predicted by the line graph was in good agreement with the actual observed values. The ROC curve and decision curve analysis (DCA), which assesses clinical usefulness, showed that the nomogram provided greater net benefit than the three individual predictors. CONCLUSIONS: In this study, a static and dynamic online nomogram with good differentiation, calibration and accuracy was constructed to help identify high-risk patients before thrombolysis, help physicians make decisions and improve patient outcomes.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。